In connection to the reports coming from the United States and Germany, regarding severe allergic reactions in patients after administering heparin, Polfa Warszawa S.A. states that our preparation is absolutely safe for patients.

The above declaration is based on the results of tests conducted on every batch of raw material used for the production of heparin by the Quality Control laboratories of Polfa Warszawa S.A., and additional results of tests received from the supplier, which excluded the presence of impurity causing allergic reactions in patients.

Moreover, tests conducted on samples from the last several deliveries of medicine in an independent laboratory confirmed the absence of the mentioned impurity, and in the same way absolute safety of heparin produced by Polfa Warszawa S.A.

We also point out that the company’s strict compliance with Good Manufacturing Practice guarantees full safety in administering all medicines produced by our company.